For the quarter ending 2025-09-30, ABSI had -$28,416K decrease in cash & cash equivalents over the period. -$25,993K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -28,706 | -56,915 |
| Depreciation and amortization | 2,842 | 6,072 |
| Stock-based compensation | 4,398 | 9,666 |
| Accretion of discount on marketable securities | 648 | 1,368 |
| Other | -189 | -119 |
| Accounts receivable, net | 300 | 700 |
| Prepaid expenses and other current assets | 2,143 | -1,860 |
| Operating lease right-of-use assets and liabilities | -144 | -268 |
| Other long-term assets | -335 | 86 |
| Accounts payable | -3,612 | 4,669 |
| Accrued expenses and other liabilities | 2,514 | -1,361 |
| Deferred revenue | 622 | -162 |
| Net cash used in operating activities | -25,031 | -38,712 |
| Purchases of property and equipment | 962 | 248 |
| Investment in marketable securities | 76,931 | 57,940 |
| Proceeds from maturities of marketable securities | 14,191 | 51,000 |
| Proceeds from sales of property and equipment | 0 | 1,183 |
| Net cash used in investing activities | -63,702 | -6,005 |
| Principal payments on long-term debt | 776 | 1,843 |
| Principal payments on finance lease obligations | 5 | 72 |
| Proceeds from issuance of common stock, net | 60,647 | 41,689 |
| Proceeds from issuance of common stock through employee equity plans, net | 451 | 2,016 |
| Net cash provided by financing activities | 60,317 | 41,790 |
| Net decrease in cash, cash equivalents, and restricted cash | -28,416 | -2,927 |
| Cash and cash equivalents at beginning of period | 58,214 | - |
| Cash and cash equivalents at end of period | 26,871 | - |
Absci Corp (ABSI)
Absci Corp (ABSI)